Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $302.92 | 15 | 91.4% |
| Education | $28.48 | 1 | 8.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $121.91 | 6 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $55.78 | 4 | $0 (2017) |
| Meridian Bioscience Inc. | $34.27 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $28.48 | 1 | $0 (2021) |
| Janssen Biotech, Inc. | $27.27 | 1 | $0 (2019) |
| Amarin Pharma Inc. | $24.62 | 1 | $0 (2019) |
| Aurinia Pharma U.S., Inc. | $21.48 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $17.59 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50.26 | 2 | Meridian Bioscience Inc. ($34.27) |
| 2023 | $92.48 | 4 | PFIZER INC. ($92.48) |
| 2022 | $17.59 | 1 | E.R. Squibb & Sons, L.L.C. ($17.59) |
| 2021 | $49.96 | 2 | Janssen Pharmaceuticals, Inc ($28.48) |
| 2019 | $51.89 | 2 | Janssen Biotech, Inc. ($27.27) |
| 2018 | $13.44 | 1 | PFIZER INC. ($13.44) |
| 2017 | $55.78 | 4 | Merck Sharp & Dohme Corporation ($55.78) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/12/2024 | Meridian Bioscience Inc. | — | Food and Beverage | Cash or cash equivalent | $34.27 | General |
| 12/14/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/07/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/17/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/02/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/27/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.59 | General |
| Category: Cardiovascular | ||||||
| 12/16/2021 | Aurinia Pharma U.S., Inc. | — | Food and Beverage | In-kind items and services | $21.48 | General |
| 10/11/2021 | Janssen Pharmaceuticals, Inc | — | Education | In-kind items and services | $28.48 | General |
| 11/21/2019 | Janssen Biotech, Inc. | Symtuza (Drug) | Food and Beverage | In-kind items and services | $27.27 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 11/05/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Hypertriglyceridemia | ||||||
| 10/10/2018 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: VACCINES | ||||||
| 10/11/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $15.79 | General |
| 04/19/2017 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: VACCINE | ||||||
| 03/01/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/03/2017 | Merck Sharp & Dohme Corporation | PNEUMOVAX 23 (Biological) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: VACCINE | ||||||
About Dr. Charles Berman, MD
Dr. Charles Berman, MD is a Infectious Disease healthcare provider based in Jamaica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780763664.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Berman, MD has received a total of $331.40 in payments from pharmaceutical and medical device companies, with $50.26 received in 2024. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($302.92).
Practice Information
- Specialty Infectious Disease
- Location Jamaica, NY
- Active Since 11/03/2006
- Last Updated 07/16/2007
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1780763664
Products in Payments
- ELIQUIS (Drug) $126.06
- PNEUMOVAX 23 (Biological) $27.37
- Symtuza (Drug) $27.27
- Vascepa (Drug) $24.62
- PREVNAR - 13 (Biological) $13.44
- JANUVIA (Drug) $12.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Jamaica
Dr. Sonia Punj, M.d, M.D
Infectious Disease — Payments: $41,898
Dr. Roxanne Cox-Iyamu, Md, MD
Infectious Disease — Payments: $3,133
Dr. Jonathan Samuels, Md, MD
Infectious Disease — Payments: $895.10
Dr. Jazila Mantis, Md, MD
Infectious Disease — Payments: $381.44
Barbara Berger, Md, MD
Infectious Disease — Payments: $163.45
Dr. Erfidia Restrepo, Md, MD
Infectious Disease — Payments: $158.17